Summary & Overview
HCPCS Q4335: Amnioplast 2, Per Square Centimeter (Add-on)
HCPCS Level II code Q4335 denotes an add-on service for application of an amniotic membrane product billed per square centimeter. As an add-on biomaterial or surgical adjunct code, it captures incremental material and application effort associated with procedures that use amnioplast products. Nationally, accurate use of add-on codes like Q4335 ensures clearer resource tracking and supports consistent facility and professional billing for adjunctive materials.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for amnioplast use, guidance on typical sites of service, and what to expect from payer coverage patterns and coding practice. The publication summarizes common modifiers and administrative considerations, explains where Q4335 appears relative to primary procedures, and identifies gaps where input data are not available. It also outlines benchmarks and policy updates relevant to add-on biomaterial codes to help coding, billing, and revenue teams align claims with clinical documentation.
This national summary aims to clarify the purpose of Q4335, support accurate reporting of amniotic membrane applications, and highlight areas where payers commonly evaluate medical necessity and documentation for adjunctive products.
Billing Code Overview
HCPCS Level II code Q4335 describes Amnioplast 2, billed per square centimeter and is designated as an add-on procedure to be reported in addition to a primary procedure. The service involves placement or application of an amniotic membrane product measured and reported by the square centimeter.
-
Service type: Surgical adjunct / biomaterial application
-
Typical site of service: Operative suite, ambulatory surgical center, or other procedural setting where the primary procedure is performed
Clinical & Coding Specifications
Clinical Context
A patient undergoing an abdominal or pelvic surgical procedure (for example, repair of a uterine or bladder defect) requires placement of amniotic membrane graft material to promote wound healing. The typical patient is an adult female with a defect or tissue loss after reconstructive pelvic surgery, fistula repair, or urologic/gynecologic procedure where biologic scaffold augmentation is used. The workflow: the primary surgeon performs the primary operative procedure (e.g., fistula repair, vaginal wall repair, or bladder reconstruction). When additional surface area of amniotic membrane is needed to cover the defect, the surgical team measures the graft area in square centimeters and bills the amnioplastic add-on code per square centimeter in addition to the primary procedure. Sterile preparation and fixation of the amniotic membrane to the wound bed occur intraoperatively; documentation includes size in cm2, source/manufacturer of the amniotic product, indication for use, and how the graft contributed to the repair.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typically required for the primary procedure due to complexity of graft placement. |
23 |